News Releases

Researchers from the Abramson Cancer Center and Perelman School of Medicine at the University of Pennsylvania will present data on the latest advances in blood cancer and benign hematology research at the ASH Annual Meeting 2023.

Lidocaine has long been suggested to have some anti-cancer effects, but it wasn’t known how or why. A new preclinical study reveals the drug activates a bitter taste receptor through two unique mechanisms that result in cancer cell death.

Penn Medicine researchers reported the first clinical trial results to show it’s possible to detect and treat dormant tumor cells in breast cancer survivors and received a $10 million grant to support their work to prevent breast cancer recurrence.

A broad new strategy could hold hope for treating virtually all blood cancers with CAR T cell therapy, which is currently approved for five subtypes of blood cancer. A new preclinical, proof-of-concept study details the “epitope-editing” approach.

Penn Medicine Neurosurgeon named Cancer Moonshot Scholar by White House for brain tumor research

Researchers found that “nudges” from electronic health records improved the implementation of tobacco use treatment almost three-fold over standard care among patients with cancer.

In new preclinical research, an experimental antibody treatment largely prevented a bone marrow transplant complication called graft versus host disease in the intestines, without causing broad immune suppression, paving the way for clinical trials.

A new study from Penn Medicine’s Abramson Cancer Center suggests that it’s reasonable for patients with advanced lung cancer to stop immunotherapy treatment at two years, as long as their cancer hasn’t progressed.

As part of a continued focus on making cancer screenings more accessible to the greater Philadelphia community, Penn Medicine is providing free cancer screenings, no insurance required, including advanced 3D mammograms.

Researchers from the Abramson Cancer Center and Perelman School of Medicine at the University of Pennsylvania will present data on the latest advances in clinical cancer research at the 2023 ASCO Annual Meeting.